- Home
- UBX vs ABVC Comparison
UBX vs ABVC Comparison
Compare UBX & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- ABVC
- Stock Information
- Founded
- UBX 2009
- ABVC 2015
- Country
- UBX United States
- ABVC United States
- Employees
- UBX N/A
- ABVC N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- UBX Health Care
- ABVC Health Care
- Exchange
- UBX Nasdaq
- ABVC Nasdaq
- Market Cap
- UBX 20.4M
- ABVC 16.7M
- IPO Year
- UBX 2018
- ABVC N/A
- Fundamental
- Price
- UBX $1.06
- ABVC $1.11
- Analyst Decision
- UBX Strong Buy
- ABVC
- Analyst Count
- UBX 3
- ABVC 0
- Target Price
- UBX $5.33
- ABVC N/A
- AVG Volume (30 Days)
- UBX 227.8K
- ABVC 282.7K
- Earning Date
- UBX 05-13-2025
- ABVC 05-16-2025
- Dividend Yield
- UBX N/A
- ABVC N/A
- EPS Growth
- UBX N/A
- ABVC N/A
- EPS
- UBX N/A
- ABVC N/A
- Revenue
- UBX N/A
- ABVC $509,788.00
- Revenue This Year
- UBX N/A
- ABVC N/A
- Revenue Next Year
- UBX N/A
- ABVC N/A
- P/E Ratio
- UBX N/A
- ABVC N/A
- Revenue Growth
- UBX N/A
- ABVC N/A
- 52 Week Low
- UBX $0.94
- ABVC $0.40
- 52 Week High
- UBX $3.10
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- UBX 31.85
- ABVC 68.65
- Support Level
- UBX $1.16
- ABVC $0.65
- Resistance Level
- UBX $1.22
- ABVC $1.40
- Average True Range (ATR)
- UBX 0.13
- ABVC 0.10
- MACD
- UBX -0.06
- ABVC 0.05
- Stochastic Oscillator
- UBX 12.22
- ABVC 62.66
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.